Strategies and New Developments in the Generation of Patient-Specific Pluripotent Stem Cells

Cell Stem Cell

Volumn 1, Issue 1, 2007, Pages 39-49

  Yamanaka, Shinya ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

BONE MARROW CELL; CELL CULTURE; CELL FUSION; CELL NUCLEUS TRANSPLANTATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; EMBRYONIC STEM CELL; FIBROBLAST; GERM LINE; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOSIS; NONHUMAN; OOCYTE; PARTHENOGENESIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SOMATIC CELL; SPERMATOGONIUM; ZYGOTE;

ANIMALS; CELL FUSION; CELL NUCLEUS; HUMANS; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; TRANSCRIPTION FACTORS;

IPS;

EID: 34249863603     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2007.05.012     Document Type: Review

References (100)

1. Adhikary S., and Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6 (2005) 635-645
2. Allen N.D., Barton S.C., Hilton K., Norris M.L., and Surani M.A. A functional analysis of imprinting in parthenogenetic embryonic stem cells. Development 120 (1994) 1473-1482
3. Avilion A.A., Nicolis S.K., Pevny L.H., Perez L., Vivian N., and Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17 (2003) 126-140
4. Baudino T.A., McKay C., Pendeville-Samain H., Nilsson J.A., Maclean K.H., White E.L., Davis A.C., Ihle J.N., and Cleveland J.L. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev. 16 (2002) 2530-2543
5. Blelloch R., Wang Z., Meissner A., Pollard S., Smith A., and Jaenisch R. Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus. Stem Cells 24 (2006) 2007-2013
6. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., Guenther M.G., Kumar R.M., Murray H.L., Jenner R.G., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122 (2005) 947-956
7. Boyer L.A., Plath K., Zeitlinger J., Brambrink T., Medeiros L.A., Lee T.I., Levine S.S., Wernig M., Tajonar A., Ray M.K., et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441 (2006) 349-353
8. Briggs R., and King T.J. Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc. Natl. Acad. Sci. USA 38 (1952) 455-463
9. Bromhall J.D. Nuclear transplantation in the rabbit egg. Nature 258 (1975) 719-722
10. Cartwright P., McLean C., Sheppard A., Rivett D., Jones K., and Dalton S. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132 (2005) 885-896
11. Cawley S., Bekiranov S., Ng H.H., Kapranov P., Sekinger E.A., Kampa D., Piccolboni A., Sementchenko V., Cheng J., Williams A.J., et al. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116 (2004) 499-509
12. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., and Smith A. Functional expression cloning of nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113 (2003) 643-655
13. Chen X., Johns D.C., Geiman D.E., Marban E., Dang D.T., Hamlin G., Sun R., and Yang V.W. Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J. Biol. Chem. 276 (2001) 30423-30428
14. Chew J.L., Loh Y.H., Zhang W., Chen X., Tam W.L., Yeap L.S., Li P., Ang Y.S., Lim B., Robson P., and Ng H.H. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol. Cell. Biol. 25 (2005) 6031-6046
15. Cibelli J.B., Grant K.A., Chapman K.B., Cunniff K., Worst T., Green H.L., Walker S.J., Gutin P.H., Vilner L., Tabar V., et al. Parthenogenetic stem cells in nonhuman primates. Science 295 (2002) 819
16. Cowan C.A., Atienza J., Melton D.A., and Eggan K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309 (2005) 1369-1373
17. Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R.C., and Croce C.M. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 79 (1982) 7824-7827
18. Darr H., Mayshar Y., and Benvenisty N. Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development 133 (2006) 1193-1201
19. Davis A.C., Wims M., Spotts G.D., Hann S.R., and Bradley A. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7 (1993) 671-682
20. Do J.T., and Scholer H.R. Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 22 (2004) 941-949
21. Egli D., Rosains J., Birkhoff G., and Eggan K. Developmental reprogramming after chromosome transfer into mitotic mouse zygotes. Nature (2007) 10.1038/nature05879 in press. Published online June 6, 2007
22. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
23. Fernandez P.C., Frank S.R., Wang L., Schroeder M., Liu S., Greene J., Cocito A., and Amati B. Genomic targets of the human c-Myc protein. Genes Dev. 17 (2003) 1115-1129
24. Foster K.W., Ren S., Louro I.D., Lobo-Ruppert S.M., McKie-Bell P., Grizzle W., Hayes M.R., Broker T.R., Chow L.T., and Ruppert J.M. Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ. 10 (1999) 423-434
25. Foster K.W., Frost A.R., McKie-Bell P., Lin C.Y., Engler J.A., Grizzle W.E., and Ruppert J.M. Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res. 60 (2000) 6488-6495
26. Foster K.W., Liu Z., Nail C.D., Li X., Fitzgerald T.J., Bailey S.K., Frost A.R., Louro I.D., Townes T.M., Paterson A.J., et al. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 24 (2005) 1491-1500
27. Garrett-Sinha L.A., Eberspaecher H., Seldin M.F., and de Crombrugghe B. A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J. Biol. Chem. 271 (1996) 31384-31390
28. Gonda K., Fowler J., Katoku-Kikyo N., Haroldson J., Wudel J., and Kikyo N. Reversible disassembly of somatic nucleoli by the germ cell proteins FRGY2a and FRGY2b. Nat. Cell Biol. 5 (2003) 205-210
29. Grandori C., Wu K.J., Fernandez P., Ngouenet C., Grim J., Clurman B.E., Moser M.J., Oshima J., Russell D.W., Swisshelm K., et al. Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev. 17 (2003) 1569-1574
30. Guan K., Nayernia K., Maier L.S., Wagner S., Dressel R., Lee J.H., Nolte J., Wolf F., Li M., Engel W., and Hasenfuss G. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 440 (2006) 1199-1203
31. Gurdon J.B., and Byrne J.A. The first half-century of nuclear transplantation. Proc. Natl. Acad. Sci. USA 100 (2003) 8048-8052
32. Hansis C., Barreto G., Maltry N., and Niehrs C. Nuclear reprogramming of human somatic cells by Xenopus egg extract requires BRG1. Curr. Biol. 14 (2004) 1475-1480
33. Hatano S.Y., Tada M., Kimura H., Yamaguchi S., Kono T., Nakano T., Suemori H., Nakatsuji N., and Tada T. Pluripotential competence of cells associated with Nanog activity. Mech. Dev. 122 (2005) 67-79
34. Hernandez L., Kozlov S., Piras G., and Stewart C.L. Paternal and maternal genomes confer opposite effects on proliferation, cell-cycle length, senescence, and tumor formation. Proc. Natl. Acad. Sci. USA 100 (2003) 13344-13349
35. Hochedlinger K., and Jaenisch R. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415 (2002) 1035-1038
36. Hochedlinger K., and Jaenisch R. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N. Engl. J. Med. 349 (2003) 275-286
37. Hochedlinger K., Yamada Y., Beard C., and Jaenisch R. Ectopic expression of oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121 (2005) 465-477
38. Hwang W.S., Ryu Y.J., Park J.H., Park E.S., Lee E.G., Koo J.M., Jeon H.Y., Lee B.C., Kang S.K., Kim S.J., et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 303 (2004) 1669-1674
39. Hwang W.S., Roh S.I., Lee B.C., Kang S.K., Kwon D.K., Kim S., Kim S.J., Park S.W., Kwon H.S., Lee C.K., et al. Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science 308 (2005) 1777-1783
40. Ivanova N., Dobrin R., Lu R., Kotenko I., Levorse J., DeCoste C., Schafer X., Lun Y., and Lemischka I.R. Dissecting self-renewal in stem cells with RNA interference. Nature 442 (2006) 533-538
41. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
42. Kamachi Y., Uchikawa M., and Kondoh H. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet. 16 (2000) 182-187
43. Kanatsu-Shinohara M., Inoue K., Lee J., Yoshimoto M., Ogonuki N., Miki H., Baba S., Kato T., Kazuki Y., Toyokuni S., et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell 119 (2004) 1001-1012
44. Katz J.P., Perreault N., Goldstein B.G., Lee C.S., Labosky P.A., Yang V.W., and Kaestner K.H. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129 (2002) 2619-2628
45. Katz J.P., Perreault N., Goldstein B.G., Actman L., McNally S.R., Silberg D.G., Furth E.E., and Kaestner K.H. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 128 (2005) 935-945
46. Kikyo N., Wade P.A., Guschin D., Ge H., and Wolffe A.P. Active remodeling of somatic nuclei in egg cytoplasm by the nucleosomal ATPase ISWI. Science 289 (2000) 2360-2362
47. Kim K., Lerou P., Yabuuchi A., Lengerke C., Ng K., West J., Kirby A., Daly M.J., and Daley G.Q. Histocompatible embryonic stem cells by parthenogenesis. Science 315 (2007) 482-486
48. Kimura H., Tada M., Nakatsuji N., and Tada T. Histone code modifications on pluripotential nuclei of reprogrammed somatic cells. Mol. Cell. Biol. 24 (2004) 5710-5720
49. Knoepfler P.S., Zhang X.Y., Cheng P.F., Gafken P.R., McMahon S.B., and Eisenman R.N. Myc influences global chromatin structure. EMBO J. 25 (2006) 2723-2734
50. Kuroda T., Tada M., Kubota H., Kimura H., Hatano S.Y., Suemori H., Nakatsuji N., and Tada T. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol. Cell. Biol. 25 (2005) 2475-2485
51. Li M., Pevny L., Lovell-Badge R., and Smith A. Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr. Biol. 8 (1998) 971-974
52. Li Z., Van Calcar S., Qu C., Cavenee W.K., Zhang M.Q., and Ren B. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc. Natl. Acad. Sci. USA 100 (2003) 8164-8169
53. Li Y., McClintick J., Zhong L., Edenberg H.J., Yoder M.C., and Chan R.J. Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105 (2005) 635-637
54. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., Bourque G., George J., Leong B., Liu J., et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38 (2006) 431-440
55. Maherali N., Sridharan R., Xie W., Utikal J., Eminli S., Arnold K., Stadtfeld M., Yachechko R., Tchieu J., Jaenisch R., et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1 (2007) 55-70 this issue
56. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78 (1981) 7634-7638
57. Masui S., Nakatake Y., Toyooka Y., Shimosato D., Yagi R., Takahashi K., Okochi H., Okuda A., Matoba R., Sharov A.A., et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9 (2007) 625-635
58. Matsui Y., Zsebo K., and Hogan B.L. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 70 (1992) 841-847
59. Matsumura H., Tada M., Otsuji T., Yasuchika K., Nakatsuji N., Surani A., and Tada T. Targeted chromosome elimination from ES-somatic hybrid cells. Nat. Methods 4 (2007) 23-25
60. Meshorer E., Yellajoshula D., George E., Scambler P.J., Brown D.T., and Misteli T. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev. Cell 10 (2006) 105-116
61. Miller R.A., and Ruddle F.H. Pluripotent teratocarcinoma-thymus somatic cell hybrids. Cell 9 (1976) 45-55
62. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., and Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES clls. Cell 113 (2003) 631-642
63. Nakatake Y., Fukui N., Iwamatsu Y., Masui S., Takahashi K., Yagi R., Yagi K., Miyazaki J., Matoba R., Ko M.S., and Niwa H. Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells. Mol. Cell. Biol. 26 (2006) 7772-7782
64. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Scholer H., and Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95 (1998) 379-391
65. Nishimoto M., Miyagi S., Katayanagi T., Tomioka M., Muramatsu M., and Okuda A. The embryonic Octamer factor 3/4 displays distinct DNA binding specificity from those of other Octamer factors. Biochem. Biophys. Res. Commun. 302 (2003) 581-586
66. Niwa H., Miyazaki J., and Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24 (2000) 372-376
67. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., and Mendell J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435 (2005) 839-843
68. Okamoto K., Okazawa H., Okuda A., Sakai M., Muramatsu M., and Hamada H. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60 (1990) 461-472
69. Okita K., Ichisaka T., and Yamanaka S. Generation of germ-line competent induced pluripotent stem cells. Nature (2007) 10.1038/nature05934 in press. Published online June 6, 2007
70. Okumura-Nakanishi S., Saito M., Niwa H., and Ishikawa F. Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J. Biol. Chem. 280 (2005) 5307-5317
71. Peukert K., Staller P., Schneider A., Carmichael G., Hanel F., and Eilers M. An alternative pathway for gene regulation by Myc. EMBO J. 16 (1997) 5672-5686
72. Rideout III W.M., Wakayama T., Wutz A., Eggan K., Jackson-Grusby L., Dausman J., Yanagimachi R., and Jaenisch R. Generation of mice from wild-type and targeted ES cells by nuclear cloning. Nat. Genet. 24 (2000) 109-110
73. Rodda D.J., Chew J.L., Lim L.H., Loh Y.H., Wang B., Ng H.H., and Robson P. Transcriptional regulation of Nanog by OCT4 and SOX2. J. Biol. Chem. 280 (2005) 24731-24737
74. Rosner M.H., Vigano M.A., Ozato K., Timmons P.M., Poirier F., Rigby P.W., and Staudt L.M. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345 (1990) 686-692
75. Rowland B.D., and Peeper D.S. KLF4, p21 and context-dependent opposing forces in cancer. Nat. Rev. Cancer 6 (2006) 11-23
76. Rowland B.D., Bernards R., and Peeper D.S. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol. 7 (2005) 1074-1082
77. Scholer H.R., Ruppert S., Suzuki N., Chowdhury K., and Gruss P. New type of POU domain in germ line-specific protein Oct-4. Nature 344 (1990) 435-439
78. Schuh R., Aicher W., Gaul U., Cote S., Preiss A., Maier D., Seifert E., Nauber U., Schroder C., Kemler R., et al. A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Kruppel, a Drosophila segmentation gene. Cell 47 (1986) 1025-1032
79. Segre J.A., Bauer C., and Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 22 (1999) 356-360
80. Shields J.M., Christy R.J., and Yang V.W. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J. Biol. Chem. 271 (1996) 20009-20017
81. Shimozaki K., Nakashima K., Niwa H., and Taga T. Involvement of Oct3/4 in the enhancement of neuronal differentiation of ES cells in neurogenesis-inducing cultures. Development 130 (2003) 2505-2512
82. Silva J., Chambers I., Pollard S., and Smith A. Nanog promotes transfer of pluripotency after cell fusion. Nature 441 (2006) 997-1001
83. Strelchenko N., Kukharenko V., Shkumatov A., Verlinsky O., Kuliev A., and Verlinsky Y. Reprogramming of human somatic cells by embryonic stem cell cytoplast. Reprod. Biomed. Online 12 (2006) 107-111
84. Tada M., Takahama Y., Abe K., Nakatsuji N., and Tada T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11 (2001) 1553-1558
85. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
86. Takahashi K., Mitsui K., and Yamanaka S. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 423 (2003) 541-545
87. Tamada H., Thuan N.V., Reed P., Nelson D., Katoku-Kikyo N., Wudel J., Wakayama T., and Kikyo N. Chromatin decondensation and nuclear reprogramming by nucleoplasmin. Mol. Cell. Biol. 26 (2006) 1259-1271
88. Taranger C.K., Noer A., Sorensen A.L., Hakelien A.M., Boquest A.C., and Collas P. Induction of dedifferentiation, genome-wide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol. Biol. Cell 16 (2005) 5719-5735
89. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
90. Tokuzawa Y., Kaiho E., Maruyama M., Takahashi K., Mitsui K., Maeda M., Niwa H., and Yamanaka S. Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol. Cell. Biol. 23 (2003) 2699-2708
91. Tomioka M., Nishimoto M., Miyagi S., Katayanagi T., Fukui N., Niwa H., Muramatsu M., and Okuda A. Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res. 30 (2002) 3202-3213
92. Wakayama T., Tabar V., Rodriguez I., Perry A.C., Studer L., and Mombaerts P. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 292 (2001) 740-743
93. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E., and Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES cell-like state. Nature (2007) 10.1038/nature05944 in press. Published online June 6, 2007
94. Wilmut I., Schnieke A.E., McWhir J., Kind A.J., and Campbell K.H. Viable offspring derived from fetal and adult mammalian cells. Nature 385 (1997) 810-813
95. Wilson M., and Koopman P. Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. Curr. Opin. Genet. Dev. 12 (2002) 441-446
96. Yu J., Vodyanik M.A., He P., Slukvin I.I., and Thomson J.A. Human embryonic stem cells reprogram myeloid precursors following cell-cell fusion. Stem Cells 24 (2006) 168-176
97. Yuan H., Corbi N., Basilico C., and Dailey L. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9 (1995) 2635-2645
98. Zaehres H., Lensch M.W., Daheron L., Stewart S.A., Itskovitz-Eldor J., and Daley G.Q. High-efficiency RNA interference in human embryonic stem cells. Stem Cells 23 (2005) 299-305
99. Zappone M.V., Galli R., Catena R., Meani N., De Biasi S., Mattei E., Tiveron C., Vescovi A.L., Lovell-Badge R., Ottolenghi S., and Nicolis S.K. Sox2 regulatory sequences direct expression of a (beta)-geo transgene to telencephalic neural stem cells and precursors of the mouse embryo, revealing regionalization of gene expression in CNS stem cells. Development 127 (2000) 2367-2382
100. Zeineddine D., Papadimou E., Chebli K., Gineste M., Liu J., Grey C., Thurig S., Behfar A., Wallace V.A., Skerjanc I.S., and Puceat M. Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev. Cell 11 (2006) 535-546